Figure 1: A metabolic use-case comprehensive patient journey view with taXonomy Pathways In clinical trials, GLP-1 drugs showed high adherence (over 85% of patients stayed on therapy), yet real-world use tells a different story: one large study found only 32% of obese patients remained on a GLP-1 therapy after one year, with just 27% meeting standard adherence thresholds
E.FernandesT
Essentials: Food & Supplements for Brain Health & Cognitive Performance In this Huberman Lab Essentials episode, I discuss science-supported nutrients that directly support brain structure, function and long-term cognitive health
Beyond appetite control, semaglutide also helps regulate blood sugar levels by supporting healthy insulin secretion and reducing glucagon release
In this blog post, we will delve into the remarkable pros and potential cons of GLP-1 medications, and explore why beginning your treatment at The Johnson Center can provide a unique and effective path to achieving your health goals
It has also been used in clinical research as a surrogate measure for gastric emptying [43]